Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2091
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI) ; volume:10 ; number:1 ; day:05 ; month:5 ; year:2009 ; pages:1-15 ; date:12.2009
BMC biochemistry ; 10, Heft 1 (05.5.2009), 1-15, 12.2009
- Creator
-
Valnickova, Zuzana
- Contributor
-
Thaysen-Andersen, Morten
Højrup, Peter
Christensen, Trine
Sanggaard, Kristian W.
Kristensen, Torsten
Enghild, Jan J.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2091-10-13
- URN
-
urn:nbn:de:1111-201603028990
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Valnickova, Zuzana
- Thaysen-Andersen, Morten
- Højrup, Peter
- Christensen, Trine
- Sanggaard, Kristian W.
- Kristensen, Torsten
- Enghild, Jan J.
- SpringerLink (Online service)
Other Objects (12)
High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke
A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor
Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis
Untersuchungen zur interindividuellen Variation der Konzentration von Thrombin Activatable Fibrinolysis Inhibitor (TAFI) und seiner Korrelation zu Parametern des Stoffwechsels und der Blutgerinnung
Determination of thrombin activatable fibrinolysis inhibitor (TAFI) activity by liquid chromatography/electrospray ionization mass spectrometry and its potential role in hemophilia : = Bestimmung der Thrombin-aktivierbarer Fibrinolyseinhibitor (TAFI)-Aktivität durch Flüssigkeitschromatographie/Tandem-Massenspektrometrie und die mögliche Rolle bei Hämophilie-Patienten
Measuring Fibrinolysis
Large-scale preparation of active caspase-3 in E. coli by designing its thrombin-activatable precursors
Structural and kinetic characterization of the leech derived inhibitor haemadin in complex with human α-thrombin [alpha-thrombin] : structural analysis of the tsetse thrombin inhibitor in complex with bovine α-thrombin [alpha-thrombin]
Extent of peritoneal metastases from colorectal cancer is not associated with changes in thrombin generation or fibrinolysis
Familial Primary Fibrinolysis
High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke
A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor
Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis
Untersuchungen zur interindividuellen Variation der Konzentration von Thrombin Activatable Fibrinolysis Inhibitor (TAFI) und seiner Korrelation zu Parametern des Stoffwechsels und der Blutgerinnung
Determination of thrombin activatable fibrinolysis inhibitor (TAFI) activity by liquid chromatography/electrospray ionization mass spectrometry and its potential role in hemophilia : = Bestimmung der Thrombin-aktivierbarer Fibrinolyseinhibitor (TAFI)-Aktivität durch Flüssigkeitschromatographie/Tandem-Massenspektrometrie und die mögliche Rolle bei Hämophilie-Patienten
Measuring Fibrinolysis
Large-scale preparation of active caspase-3 in E. coli by designing its thrombin-activatable precursors
Structural and kinetic characterization of the leech derived inhibitor haemadin in complex with human α-thrombin [alpha-thrombin] : structural analysis of the tsetse thrombin inhibitor in complex with bovine α-thrombin [alpha-thrombin]
Extent of peritoneal metastases from colorectal cancer is not associated with changes in thrombin generation or fibrinolysis
Familial Primary Fibrinolysis
High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke
A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor
Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis
Untersuchungen zur interindividuellen Variation der Konzentration von Thrombin Activatable Fibrinolysis Inhibitor (TAFI) und seiner Korrelation zu Parametern des Stoffwechsels und der Blutgerinnung
Determination of thrombin activatable fibrinolysis inhibitor (TAFI) activity by liquid chromatography/electrospray ionization mass spectrometry and its potential role in hemophilia : = Bestimmung der Thrombin-aktivierbarer Fibrinolyseinhibitor (TAFI)-Aktivität durch Flüssigkeitschromatographie/Tandem-Massenspektrometrie und die mögliche Rolle bei Hämophilie-Patienten
Measuring Fibrinolysis
Large-scale preparation of active caspase-3 in E. coli by designing its thrombin-activatable precursors
Structural and kinetic characterization of the leech derived inhibitor haemadin in complex with human α-thrombin [alpha-thrombin] : structural analysis of the tsetse thrombin inhibitor in complex with bovine α-thrombin [alpha-thrombin]
Extent of peritoneal metastases from colorectal cancer is not associated with changes in thrombin generation or fibrinolysis